companydata.dkcompanydata.dk

TFS TRIAL FORM SUPPORT ApS: Financial statements 2024

CVR: 10064627

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

TFS TRIAL FORM SUPPORT ApS (CVR 10064627) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 11,329,008 and a net result of DKK -1,834,180 compared with DKK 1,243,703 the year before. That is a decrease of 42% compared with the year before. Equity in the 2024 report amounted to DKK 2,596,341. The solvency ratio was 56.1%. The company had 14 employees in the financial year.

Gross Profit
DKK 11,329,008
Profit/Loss
DKK -1,834,180
Equity
DKK 2,596,341
Total Assets
DKK 4,630,085
Employees
14

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-11.3 mio.-1.8 mio.2.6 mio.14
2023-19.5 mio.1.2 mio.4.4 mio.22
2022-19 mio.-1.6 mio.1.2 mio.26
2021-15.3 mio.-1.9 mio.2.8 mio.21
2020-12 mio.-591 t.4.6 mio.17

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

TFS TRIAL FORM SUPPORT ApS appoints new auditorOct 1, 2024

As of October 1, 2024, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of TFS TRIAL FORM SUPPORT ApS.

Auditor steps down at TFS TRIAL FORM SUPPORT ApSOct 1, 2024

As of October 1, 2024, EMIT P/S has stepped down as auditor of TFS TRIAL FORM SUPPORT ApS.

TFS TRIAL FORM SUPPORT ApS: The 2023 annual report is outJun 4, 2024

TFS TRIAL FORM SUPPORT ApS has published its annual report for 2023. Gross profit came to DKK 19,548,894, and the net result was DKK 1,243,703.

About TFS TRIAL FORM SUPPORT ApS

TFS TRIAL FORM SUPPORT ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2001. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jan Markus Granlund. The board consists of Jesper Hjort (chair) and Jan Markus Granlund. The company is owned by TFS International Clinical Development Services AB. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 8,921,130 and a net result of DKK -845,854 compared with DKK -1,834,180 the year before. Equity in the 2025 report amounted to DKK 1,750,487.

Source: annual report 2025, Danish Business Authority